(2007). "Irinotecan, docetaxel and oxaliplatin combination in metastatic gastric or gastroesophageal junction adenocarcinoma." British Journal of Cancer 97(5): 593-7.Di Lauro L, Nunziata C, Arena MG, et al. Iri
Food and Drug Administration (FDA) indication for the treatment of advanced or metastatic gastric/gastroesophageal junction adenocarcinoma. Gastric cancer is a prevalent cancer in the United States with a poor prognosis. The phase 3 trial, REGARD, shows that ramucirumab, when used within four months...
Keytruda , in combination with fluoropyrimidine- and platinum-containing chemotherapy, is indicated for the first-line treatment of adults with locally advanced unresectable or metastatic HER2-negative gastric or gastroesophageal junction (GEJ) adenocarcinoma. Keytruda , in combination with ...
Eligible patients were aged ≥18 years of age with histologically or cytologically confirmed locally advanced or metastatic gastric or GEJ junction adenocarcinoma. Patients had to have at least one measurable lesion and have failed one prior systemic chemotherapy (including patients with disease recurrence...
in which sugemalimab in combination with chemotherapy is used as a first-line treatment of unresectable locally advanced or metastatic gastric adenocarcinoma/gastro-esophageal junction (GEJ) adenocarcinoma with PD-L1 expression ≥5%, has met one of its primary endpoints, progression-free survival (PFS...
197TiP - GLOW: Zolbetuximab + CAPOX compared with placebo + CAPOX as first-line treatment for patients with Claudin18.2+/HER2– Locally advanced unresectable or metastatic gastric or gastroesophageal junction (GEJ) adenocarcinoma: A randomized phase III study...
adenocarcinoma of the gastroesophageal junction (GEJ). Thepatient is a 58-year-old female who had presented with early satiety and dysphagia for which sheunderwent esophagogastroduodenoscopy which showed an esophageal mass and endoscopic ultrasounds(EUSs) confirmed adenocarcinoma of the GEJ with ...
doi:10.20517/2394-4722.2017.82Tasuku ToihataYu ImamuraMasayuki WatanabeHideo BabaJournal of Cancer Metastasis and Treatment癌症转移与治疗:英文版Toihata T, Imamura Y, Watanabe M, Baba H. Management of metastatic esophagogastric junction adenocarcinoma. J Cancer Metastasis Treat 2018;4:24....
(2007). "Irinotecan, docetaxel and oxaliplatin combination in metastatic gastric or gastroesophageal junction adenocarcinoma." British Journal of Cancer 97(5): 593-7.Di Lauro L, Nunziata C, Arena MG, Foggi P, Sperduti I, Lopez M. Irinote- can, docetaxel and oxaliplatin combination in ...
Ultrasound-guided biopsy revealed metastatic adenocarcinoma. Its origin was confirmed through an endoscopic biopsy of an exophytic mass forming from the cardioesophageal junction. Computed tomography staging revealed an advanced-stage disease, with metastatic deposits over multiple organs. The patient ...